Generate Biomedicines, Inc. (GENB)
NASDAQ: GENB · Real-Time Price · USD
11.51
+0.07 (0.61%)
At close: Mar 30, 2026, 4:00 PM EDT
11.51
0.00 (0.00%)
After-hours: Mar 30, 2026, 4:10 PM EDT
Generate Biomedicines Market Cap
Generate Biomedicines has a market cap or net worth of $1.47 billion as of March 30, 2026.
Market Cap
1.47B
Enterprise Value
1.30B
1-Year Change
n/a
Ranking
Category
Stock Price
$11.51
Market Cap Chart
Since the IPO on February 27, 2026, Generate Biomedicines's market cap has decreased from $2.04B to $1.47B, a decrease of -28.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 1.46B | -10.97% |
| Mar 26, 2026 | 1.64B | 8.62% |
| Mar 25, 2026 | 1.51B | -1.66% |
| Mar 24, 2026 | 1.53B | -3.91% |
| Mar 23, 2026 | 1.60B | 2.04% |
| Mar 20, 2026 | 1.56B | -0.16% |
| Mar 19, 2026 | 1.57B | 4.06% |
| Mar 18, 2026 | 1.51B | -4.45% |
| Mar 17, 2026 | 1.58B | 3.34% |
| Mar 16, 2026 | 1.52B | -8.56% |
| Mar 13, 2026 | 1.67B | -1.51% |
| Mar 12, 2026 | 1.69B | 4.40% |
| Mar 11, 2026 | 1.62B | 4.18% |
| Mar 10, 2026 | 1.56B | 0.33% |
| Mar 9, 2026 | 1.55B | 8.56% |
| Mar 6, 2026 | 1.43B | -9.96% |
| Mar 5, 2026 | 1.59B | 7.51% |
| Mar 4, 2026 | 1.48B | -2.93% |
| Mar 3, 2026 | 1.52B | -1.97% |
| Mar 2, 2026 | 1.55B | -23.94% |
| Feb 27, 2026 | 2.04B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nurix Therapeutics | 1.52B |
| Maze Therapeutics | 1.51B |
| Pharvaris | 1.50B |
| Immunocore Holdings | 1.49B |
| Vericel | 1.49B |
| Nuvation Bio | 1.48B |
| Nanobiotix | 1.46B |
| Intellia Therapeutics | 1.46B |